Carcinoma, Intraductal, Noninfiltrating
Also known as: Intraductal carcinoma in situ of breast / Non-infiltrating intraductal carcinoma (morphologic abnormality) / Ductal carcinoma in situ / Intraductal carcinoma in situ of breast (disorder) / Carcinoma in situ of breast ductal
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01592 | Iron | 0 | Withdrawn | 1 |
| DB09146 | Iron sucrose | 0 | Withdrawn | 1 |
| DB09037 | Pembrolizumab | 0 | Recruiting | 1 |
| DB00608 | Chloroquine | 1 / 2 | Completed | 1 |
| DB00675 | Tamoxifen | 3 | Active Not Recruiting | 1 |